Form 8-K - Current report:
SEC Accession No. 0001171843-25-007497
Filing Date
2025-11-21
Accepted
2025-11-21 16:30:30
Documents
17
Period of Report
2025-11-17
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K f8k_111925.htm   iXBRL 8-K 28699
2 EXHIBIT 5.1 exh_51.htm EX-5.1 36350
3 EXHIBIT 10.1 exh_101.htm EX-10.1 48997
7 GRAPHIC maples.jpg GRAPHIC 2750
8 GRAPHIC maplesfoot.jpg GRAPHIC 13544
9 GRAPHIC maplessig.jpg GRAPHIC 5616
  Complete submission text file 0001171843-25-007497.txt   331285

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE bysi-20251119.xsd EX-101.SCH 3029
5 XBRL LABEL FILE bysi-20251119_lab.xml EX-101.LAB 34239
6 XBRL PRESENTATION FILE bysi-20251119_pre.xml EX-101.PRE 22368
20 EXTRACTED XBRL INSTANCE DOCUMENT f8k_111925_htm.xml XML 3687
Mailing Address 100 CAMPUS DRIVE, WEST SIDE, 4TH FLOOR SUITE 410 FLORHAM PARK NJ 07932
Business Address 100 CAMPUS DRIVE, WEST SIDE, 4TH FLOOR SUITE 410 FLORHAM PARK NJ 07932 646-528-4184
BeyondSpring Inc. (Filer) CIK: 0001677940 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38024 | Film No.: 251508431
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)